QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=1BD4BA3675BB5A1AFF2AF3E4C72D7937;jsessionid=D532B8280E1FEC696D04F94FFCB25378;jsessionid=6409BBF47CD1D997D7323E584004D0AE;jsessionid=CB19208558106B2D8A7ADE7C69BD4489 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=1BD4BA3675BB5A1AFF2AF3E4C72D7937;jsessionid=D532B8280E1FEC696D04F94FFCB25378;jsessionid=6409BBF47CD1D997D7323E584004D0AE;jsessionid=CB19208558106B2D8A7ADE7C69BD4489